CN¥ 33.58
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of 300204.SZ is 55 and suggests 62% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
